|
KIF13A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.14250000000393E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.634100E-04 |
| Normal-vs-Stage2 |
3.961200E-03 |
| Normal-vs-Stage3 |
1.7568799999923E-05 |
| Normal-vs-Stage4 |
1.58289999996342E-06 |
| Stage1-vs-Stage2 |
8.304600E-01 |
| Stage1-vs-Stage3 |
1.321200E-01 |
| Stage1-vs-Stage4 |
2.069900E-02 |
| Stage2-vs-Stage3 |
3.889400E-01 |
| Stage2-vs-Stage4 |
1.310430E-01 |
| Stage3-vs-Stage4 |
3.868000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8236999999921E-05 |
| Normal-vs-AfricanAmerican |
2.948200E-01 |
| Normal-vs-Asian |
3.982100E-03 |
| Caucasian-vs-AfricanAmerican |
5.283900E-02 |
| Caucasian-vs-Asian |
7.893400E-01 |
| AfricanAmerican-vs-Asian |
1.730820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.73259999999887E-05 |
| Normal-vs-Female |
9.94880000000364E-05 |
| Male-vs-Female |
4.865400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.397000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.218660E-04 |
| Normal-vs-Age(61-80Yrs) |
1.23539999996591E-06 |
| Normal-vs-Age(81-100Yrs) |
2.895800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.517600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.038300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.568600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.793190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.961400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.168600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.384500E-03 |
| Classical-VS-Follicular |
6.902000E-01 |
| Classical-VS-Other |
1.797000E-01 |
| Classical-VS-Normal |
1.810450E-04 |
| Tall-VS-Follicular |
1.315820E-02 |
| Tall-VS-Other |
7.082800E-01 |
| Tall-VS-Normal |
2.63200000016894E-07 |
| Follicular-VS-Other |
2.319200E-01 |
| Follicular-VS-Normal |
7.201200E-03 |
| Other-VS-Normal |
4.162200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.46270000000038E-05 |
| Normal-vs-N1 |
2.18189999999785E-05 |
| N0-vs-N1 |
1.059350E-01 |
|
|
